Clinical trial
An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or…
NCT00379847 · Cumberland Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00379847 |
|---|---|
| Title | An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia |
| Official title | A 4-day, Open-Label, Multicenter Phase 3b Study of IV YM087 in Patients With Euvolemic or Hypervolemic Hyponatremia |
| Lead sponsor | Cumberland Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyponatremia |
| Intervention type | Drug |
| Interventions | conivaptan |
| Enrollment | 251 |
| Start date | Feb 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 25, 2006 |
| Last update posted | May 2, 2014 |
| Countries | Israel, South Africa, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: